BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
20.77
+0.78 (3.90%)
At close: Jun 18, 2026, 4:00 PM EDT
20.18
-0.59 (-2.84%)
After-hours: Jun 18, 2026, 6:56 PM EDT
BioAge Labs Revenue
BioAge Labs had revenue of $2.77M in the quarter ending March 31, 2026, with 91.04% growth. This brings the company's revenue in the last twelve months to $10.32M, up 610.96% year-over-year. In the year 2025, BioAge Labs had annual revenue of $9.00M.
Revenue (ttm)
$10.32M
Revenue Growth
+610.96%
P/S Ratio
89.50
Revenue / Employee
$166,387
Employees
62
Market Cap
923.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBIOA News
- 3 days ago - BioAge Labs doses first participant in QUELL-CV trial of BGE-102 - TheFly
- 3 days ago - BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk - GlobeNewsWire
- 11 days ago - BioAge Labs Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 14 days ago - BioAge Labs Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 23 days ago - BioAge Labs initiated with a Buy at Roth Capital - TheFly
- 4 weeks ago - BioAge Labs to Present at Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - BioAge Labs initiated with a Buy at BTIG - TheFly
- 6 weeks ago - BioAge Labs Transcript: R&D Day 2026 - Transcripts